Acerus Pharmaceuticals Corporation announced data from the phase IV Natesto (intranasal testosterone gel) Spermatogenesis Study which demonstrated that 95% of...
Clarus Therapeutics Inc. announced positive results of an open-label, multi-center safety and efficacy analysis following two years of Jatenzo (testosterone undecanoate) oral capsules use in hypogonadal men.
Lipocine announced top-line 52-week safety results from its SOAR pivotal Phase III clinical study evaluating efficacy and safety of LPCN...
Importance: Menopause, due to loss of ovarian follicular activity without another pathological or physiological cause, typically occurs between the ages of 45 years and 56 years.
With life expectancy for women on the rise, most women will experience menopausal transition and spend a significant number of years of their life in the menopausal phase.